Status:
COMPLETED
Hyperglycemia in Patients with Stroke and Indication of Enteral Nutrition
Lead Sponsor:
Endocrinology and Clinical Nutrition Research Center, Spain
Conditions:
Hyperglycaemia (Non Diabetic)
Enteral Feeding Intolerance
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of a specific nutritional formula for diabetics on the development of hyperglycemia in patients with recent non-diabetic stroke who require admissio...
Detailed Description
MAIN GOAL: To evaluate the effect on the development of hyperglycemia diagnosed as glycemia\> 126 mg / dl on an empty stomach or\> 150 mg / dl during the infusion of enteral nutrition determined by c...
Eligibility Criteria
Inclusion
- Admitted for a first episode of ischemic or hemorrhagic stroke.
- Requiring total enteral nutrition by tube for at least 7 days
Exclusion
- Contraindication to enteral nutrition
- Diabetes Mellitus
- Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting, abdominal pain
- Need for admission to the ICU
- Previous neurodegenerative disease
- Antibiotherapy for 7 days prior to the inclusion visit
- Allergies or intolerances to any of the components of the formula under study
- Pregnant patients
Key Trial Info
Start Date :
December 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT03422900
Start Date
December 12 2017
End Date
September 30 2021
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic Universitary Hospital
Valladolid, Valladolid, Spain, 47003